Eleven Therapeutic Solutions (UK) Ltd is a privately-owned Limited Company operating within the UK’s research and development sector specializing in biotechnology applications for therapeutic intervention. Established on February 10, 2021, with registration number 13192758, Eleven focuses primarily on innovative solutions for improving human health through advanced scientific exploration. The company operates from its headquarters at 35 Ballards Lane, London, N3 1XW and is currently active. Its core service offering involves the design and synthesis of novel compounds with potential pharmaceutical applications. Eleven Therapeutic Solutions’ expertise spans a range of biological research areas including drug discovery, biomarker analysis, and personalized medicine pathways. The company's strategic location within Pittsburgh’s Strip District provides access to valuable industry connections and skilled workforce opportunities. Eleven is structured as a Limited Company (Ltd) and operates under the SIC codes - 72110 – reflecting its focus on biotechnology research and development activities. The company aims for international expansion, though currently maintains limited presence across borders. Eleven Therapeutic Solutions employs a team of highly trained scientists and researchers dedicated to advancing scientific breakthroughs.

Eleven Therapeutic Solutions (UK) Ltd is a privately-owned Limited Company operating within the UK’s research and development sector specializing in biotechnology applications for therapeutic intervention. Established on February 10, 2021, with registration number 13192758, Eleven focuses primarily on innovative solutions for improving human health through advanced scientific exploration. The company operates from its headquarters at 35 Ballards Lane, London, N3 1XW and is currently active. Its core service offering involves the design and synthesis of novel compounds with potential pharmaceutical applications. Eleven Therapeutic Solutions’ expertise spans a range of biological research areas including drug discovery, biomarker analysis, and personalized medicine pathways. The company's strategic location within Pittsburgh’s Strip District provides access to valuable industry connections and skilled workforce opportunities. Eleven is structured as a Limited Company (Ltd) and operates under the SIC codes - 72110 – reflecting its focus on biotechnology research and development activities. The company aims for international expansion, though currently maintains limited presence across borders. Eleven Therapeutic Solutions employs a team of highly trained scientists and researchers dedicated to advancing scientific breakthroughs.